Vetoquinol (VETO)

Currency in EUR
74.40
-0.80(-1.06%)
Closed·
VETO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VETO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
74.4075.20
52 wk Range
63.6098.40
Key Statistics
Prev. Close
75.2
Open
75.2
Day's Range
74.4-75.2
52 wk Range
63.6-98.4
Volume
1.22K
Average Volume (3m)
3.78K
1-Year Change
-20.94%
Book Value / Share
48.67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VETO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
91.57
Upside
+23.08%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Vetoquinol News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Vetoquinol Company Profile

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Employees
2469
Market
France

Compare VETO to Peers and Sector

Metrics to compare
VETO
Peers
Sector
Relationship
P/E Ratio
15.0x19.1x−0.5x
PEG Ratio
2.510.170.00
Price/Book
1.5x2.1x2.6x
Price / LTM Sales
1.6x3.1x3.3x
Upside (Analyst Target)
18.3%19.2%43.4%
Fair Value Upside
Unlock14.8%7.1%Unlock

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 91.57
(+23.08% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.98%
Dividend Yield
1.20%
Industry Median 4.37%
Annualised payout
0.89
Paid annually
5-Years Growth
+18.56%
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
130.60M / --
EPS Revisions
Last 90 days

VETO Income Statement

People Also Watch

616.90
ASML
+1.02%
252.90
ESLX
+0.28%
106.30
IPN
-0.19%
27.51
DAST
-0.25%
51.95
EXHO
-0.57%

FAQ

What Stock Exchange Does Vetoquinol Trade On?

Vetoquinol is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Vetoquinol?

The stock symbol for Vetoquinol is "VETO."

What Is the Vetoquinol Market Cap?

As of today, Vetoquinol market cap is 877.60M.

What Is Vetoquinol's Earnings Per Share (TTM)?

The Vetoquinol EPS (TTM) is 4.98.

When Is the Next Vetoquinol Earnings Date?

Vetoquinol will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is VETO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vetoquinol Stock Split?

Vetoquinol has split 0 times.

How Many Employees Does Vetoquinol Have?

Vetoquinol has 2469 employees.

What is the current trading status of Vetoquinol (VETO)?

As of 10 Aug 2025, Vetoquinol (VETO) is trading at a price of 74.40, with a previous close of 75.20. The stock has fluctuated within a day range of 74.40 to 75.20, while its 52-week range spans from 63.60 to 98.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.